← Open Payments lookup

AUDREY STROCK: Open Payments

NPI 1356561161 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$177,686 in 342 payments from 15 companies in 2025. Trend: 2023 $124,561 · 2024 $133,717 · 2025 $177,686

Speaker / faculty: $129,255Travel & lodging: $30,880Honoraria: $13,001Food & beverage: $4,550
CompanyPaymentsAmount
ABBVIE INC.261$155,100
Axsome Therapeutics, Inc.24$15,572
Vanda Pharmaceuticals Inc.20$6,113
Alkermes, Inc.9$312
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$144
Takeda Pharmaceuticals U.S.A., Inc.5$111
Collegium Pharmaceutical, Inc.4$70
Supernus Pharmaceuticals, Inc.3$55
Teva Pharmaceuticals USA, Inc.3$48
Otsuka America Pharmaceutical, Inc.2$47

Products named: VRAYLAR, Auvelity, FANAPT, CAPLYTA, ARISTADA, LYBALVI, TRINTELLIX, REXULTI.

Industry payments across CO — which companies pay providers there.